171 related articles for article (PubMed ID: 27094700)
1. Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.
Matieli L; Berezovsky A; Salomão SR; Allemann N; Martins EN; Hirai FE; Ota-Arakaki J; Morales MS; de Freitas D
Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1167-74. PubMed ID: 27094700
[TBL] [Abstract][Full Text] [Related]
2. Ocular perfusion pressure and color Doppler imaging of the external ophthalmic artery of rabbits treated with sildenafil citrate.
Costa AP; Lima AM; da Silva LH; de Oliveira Alves Carvalho R; do Amaral AV; Borges NC
BMC Vet Res; 2016 Jul; 12(1):149. PubMed ID: 27449366
[TBL] [Abstract][Full Text] [Related]
3. VISION LOSS IN A PATIENT WITH PRIMARY PULMONARY HYPERTENSION AND LONG-TERM USE OF SILDENAFIL.
Sajjad A; Weng CY
Retin Cases Brief Rep; 2017 Fall; 11(4):325-328. PubMed ID: 27355186
[TBL] [Abstract][Full Text] [Related]
4. ERG evaluation of daily, high-dose sildenafil usage.
Zoumalan CI; Zamanian RT; Doyle RL; Marmor MF
Doc Ophthalmol; 2009 Jun; 118(3):225-31. PubMed ID: 18818963
[TBL] [Abstract][Full Text] [Related]
5. The effects of sildenafil on ocular blood flow.
Koksal M; Ozdemir H; Kargi S; Yesilli C; Tomaç S; Mahmutyazicioglu K; Mungan A
Acta Ophthalmol Scand; 2005 Jun; 83(3):355-9. PubMed ID: 15948790
[TBL] [Abstract][Full Text] [Related]
6. Effect of sildenafil on ocular haemodynamics.
Dündar SO; Dündar M; Koçak I; Dayanir Y; Ozkan SB
Eye (Lond); 2001 Aug; 15(Pt 4):507-10. PubMed ID: 11767027
[TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil on ocular hemodynamics in 3 months regular use.
Dündar SO; Dayanir Y; Topaloğlu A; Dündar M; Koçak I
Int J Impot Res; 2006; 18(3):282-6. PubMed ID: 16292333
[TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil on ocular perfusion demonstrated by color Doppler ultrasonography.
Kurtulan E; Gulcu A; Secil M; Celebi I; Aslan G; Esen AA
Int J Impot Res; 2004 Jun; 16(3):244-8. PubMed ID: 14973526
[TBL] [Abstract][Full Text] [Related]
9. [Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study].
Volkov AV; Nikolaeva EV; Yudkina NN; Kurmukov IA; Nasonov EL
Ter Arkh; 2015; 87(11):62-67. PubMed ID: 26821419
[TBL] [Abstract][Full Text] [Related]
10. Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia.
Bialkowski A; Moenkemeyer F; Patel N
Eur J Pediatr Surg; 2015 Apr; 25(2):171-6. PubMed ID: 24163194
[TBL] [Abstract][Full Text] [Related]
11. Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yang X; Sanders KN; Mardekian J; Mychaskiw MA; Thomas J
Clin Ther; 2015 May; 37(5):1055-63. PubMed ID: 25818118
[TBL] [Abstract][Full Text] [Related]
12. Bilateral posterior ischemic optic neuropathy associated with the use of Sildenafil for pulmonary hypertension.
Coca MN; Morgan ML; Gupta P; Elkeeb A; Lee AG
Can J Ophthalmol; 2016 Jun; 51(3):e96-9. PubMed ID: 27316292
[No Abstract] [Full Text] [Related]
13. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
[TBL] [Abstract][Full Text] [Related]
14. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
15. Value of duplex and color doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease.
Aikimbaev K; Guvenc B; Canataroglu A; Canataroglu H; Baslamisli F; Oguz M
Am J Hematol; 2001 Jul; 67(3):163-7. PubMed ID: 11391712
[TBL] [Abstract][Full Text] [Related]
16. [Ocular blood flow and retinal electrogenesis in retinitis pigmentosa].
Kiseleva TN; Zol'nikova IV; Demenkova ON; Ramazanova KA; Egorova IV; Rogatina EV; Rogova SY; Kiseleva TN; Zol'nikova IV; Demenkova ON; Ramazanova KA; Egorova IV; Rogatina EV; Rogova SY
Vestn Oftalmol; 2015; 131(5):14-19. PubMed ID: 26845867
[TBL] [Abstract][Full Text] [Related]
17. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
18. Color Doppler evaluation of the ocular arterial flow changes in chronic obstructive pulmonary disease.
Ozer T; Altin R; Ugurbas SH; Ozer Y; Mahmutyazicioglu K; Kart L
Eur J Radiol; 2006 Jan; 57(1):63-8. PubMed ID: 16051458
[TBL] [Abstract][Full Text] [Related]
19. SILDENAFIL CITRATE INDUCED RETINAL TOXICITY-ELECTRORETINOGRAM, OPTICAL COHERENCE TOMOGRAPHY, AND ADAPTIVE OPTICS FINDINGS.
Yanoga F; Gentile RC; Chui TYP; Freund KB; Fell M; Dolz-Marco R; Rosen RB
Retin Cases Brief Rep; 2018 Fall; 12 Suppl 1(Suppl 1):S33-S40. PubMed ID: 29489563
[TBL] [Abstract][Full Text] [Related]
20. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
